Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Xerox XRX Jul 11, 2025 5.10 -0.78   
 XIAO-I ADR AIXI Jul 11, 2025 2.33 -3.32   
 Xilio Therapeutics XLO Jul 11, 2025 0.73 -1.32   
 Xinyuan Real Estate ADR XIN Jul 11, 2025 2.08 0.00   
 XOMA XOMA Jul 11, 2025 27.14 -2.72   
 XOMA A Pref XOMAP Jul 11, 2025 25.65 0.00   
 XOMA B Pref XOMAO Jul 11, 2025 25.49 +0.55   
 Xometry A XMTR Jul 11, 2025 34.49 -4.09   
 XORTX Therapeutics XRTX Jul 11, 2025 0.96 +10.06   
 Xos XOS Jul 11, 2025 3.44 +0.88   
 XP A XP Jul 11, 2025 18.26 -1.88   
 XPEL XPEL Jul 11, 2025 35.46 -6.07   
 XPeng A ADR XPEV Jul 11, 2025 17.40 -0.17   
 Xperi XPER Jul 11, 2025 7.80 -2.13   
 XPLR Infrastructure, LP XIFR Jul 11, 2025 9.41 -0.11   
 XPO Logistics XPO Jul 11, 2025 132.35 -1.19   
 Xponential Fitness A XPOF Jul 11, 2025 10.40 +0.58   
 Xtant Medical XTNT Jul 11, 2025 0.66 -4.87   
 XTI Aerospace XTIA Jul 11, 2025 1.95 -5.80   
 XTL Biopharmaceuticals ADR XTLB Jul 11, 2025 1.51 -0.66   
 Xunlei ADR XNET Jul 11, 2025 4.59 -0.97   
 XWELL XWEL Jul 11, 2025 0.97 -2.89   
 Xylem XYL Jul 11, 2025 130.95 -0.49   
 Xylo Technologies ADR XYLO Jul 11, 2025 4.85 -0.61   
 Y-mAbs Therapeutics YMAB Jul 11, 2025 4.36 -3.54   
 Yalla ADR YALA Jul 11, 2025 7.41 -0.80   
 Yatra Online YTRA Jul 11, 2025 0.95 0.00   
 Yatsen ADR YSG Jul 11, 2025 9.62 +2.78   
 Yelp YELP Jul 11, 2025 34.16 -2.71   
 YETI YETI Jul 11, 2025 32.09 -2.40   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.